Arkolith/Insider Trading/AEON/Form 4

Forth Marc

Chief Executive Officer, DirectorAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Jul 24, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Grant(A)194K—$0194K
Jul 21, 2023Grant(A)280K—$0280K
Jul 21, 2023Grant(A)381K—$0381K
Jul 21, 2023Grant(A)291K—$0291K
Jul 21, 2023Grant(A)324K—$0324K
Jul 21, 2023Grant(A)971K—$0971K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-083566) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML